VEGF receptor 1 stimulates stem-cell recruitment and new hope for angiogenesis therapies

被引：46

作者：

Eriksson, U ^{[1
]}

Alitalo, K

机构：

[1] Ludwig Inst Canc Res, Stockholm Branch, S-10401 Stockholm, Sweden

[2] Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland

[3] Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland

[4] Univ Helsinki, Biomedicum Helsinki, FIN-00014 Helsinki, Finland

来源：

NATURE MEDICINE | 2002年 / 8卷 / 08期

关键词：

D O I：

10.1038/nm0802-775

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Efforts to control vessel growth have focused on vascular endothelial growth factor ( VEGF) and its primary receptor VEGFR-2. New data could shift that focus to other members of the VEGF family and the receptor VEGFR-1, particularly in inflammatory diseases ( pages 831 - 840 841 - 849).

引用

页码：775 / 777

页数：3

共 18 条

[1] Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect [J].

Aase, K ;

von Euler, G ;

Li, X ;

Pontén, A ;

Thorén, P ;

Cao, R ;

Cao, Y ;

Olofsson, B ;

Gebre-Medhin, S ;

Pekny, M ;

Alitalo, K ;

Betsholtz, C ;

Eriksson, U .

CIRCULATION, 2001, 104 (03) :358-364

[2] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis [J].

Bergers, G ;

Brekken, R ;

McMahon, G ;

Vu, TH ;

Itoh, T ;

Tamaki, K ;

Tanzawa, K ;

Thorpe, P ;

Itohara, S ;

Werb, Z ;

Hanahan, D .

NATURE CELL BIOLOGY, 2000, 2 (10) :737-744

[3] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].

Carmeliet, P ;

Moons, L ;

Luttun, A ;

Vincenti, V ;

Compernolle, V ;

De Mol, M ;

Wu, Y ;

Bon, F ;

Devy, L ;

Beck, H ;

Scholz, D ;

Acker, T ;

DiPalma, T ;

Dewerchin, M ;

Noel, A ;

Stalmans, I ;

Barra, A ;

Blacher, S ;

Vandendriessche, T ;

Ponten, A ;

Eriksson, U ;

Plate, KH ;

Foidart, JM ;

Schaper, W ;

Charnock-Jones, DS ;

Hicklin, DJ ;

Herbert, JM ;

Collen, D ;

Persico, MG .

NATURE MEDICINE, 2001, 7 (05) :575-583

[4] Angiogenesis in cancer and other diseases [J].

Carmeliet, P ;

Jain, RK .

NATURE, 2000, 407 (6801) :249-257

[5] Developmental control of blood cell migration by the Drosophila VEGF pathway [J].

Cho, NK ;

Keyes, L ;

Johnson, E ;

Heller, J ;

Ryner, L ;

Karim, F ;

Krasnow, MA .

CELL, 2002, 108 (06) :865-876

[6] Angiogenesis therapy - Amidst the hype, the neglected potential for serious side effects [J].

Epstein, SE ;

Kornowski, R ;

Fuchs, S ;

Dvorak, HF .

CIRCULATION, 2001, 104 (01) :115-119

[7]

Eriksson U, 1999, CURR TOP MICROBIOL, V237, P41

[8] The biology of vascular endothelial growth factor [J].

Ferrara, N ;

DavisSmyth, T .

ENDOCRINE REVIEWS, 1997, 18 (01) :4-25

[9] Clinical applications of angiogenic growth factors and their inhibitors [J].

Ferrara, N ;

Alitalo, K .

NATURE MEDICINE, 1999, 5 (12) :1359-1364

[10]

Fong GH, 1999, DEVELOPMENT, V126, P3015

← 1 2 →